Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
US8158609B1 · kind B1 · utility
29Cited by
19References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2007 |
| Grant date | Apr 17, 2012 |
| Priority date | — |
| Expiry date | May 21, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to the treatment of disorders involving the accumulation of drusen, such as dry age-related macular degeneration and geographic atrophy via administration of therapeutically effective amounts of at least one monomeric or polymeric cyclodextrin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.